<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE LIFECORE BIOMEDICAL, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE 3 MONTHS ENDED SEPTEMBER 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000028626 <NAME> LIFECORE BIOMEDICAL <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> JUN-30-1997 <PERIOD-START> JUL-01-1996 <PERIOD-END> SEP-30-1996 <CASH> 931,000 <SECURITIES> 35,086,000 <RECEIVABLES> 2,636,000 <ALLOWANCES> 298,000 <INVENTORY> 8,574,000 <CURRENT-ASSETS> 29,621,000 <PP&E> 13,488,000 <DEPRECIATION> 4,751,000 <TOTAL-ASSETS> 62,782,000 <CURRENT-LIABILITIES> 4,021,000 <BONDS> 7,142,000 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 121,000 <OTHER-SE> 51,498,000 <TOTAL-LIABILITY-AND-EQUITY> 62,782,000 <SALES> 3,568,000 <TOTAL-REVENUES> 3,568,000 <CGS> 2,098,000 <TOTAL-COSTS> 4,621,000 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 156,000 <INCOME-PRETAX> (654,000) <INCOME-TAX> 0 <INCOME-CONTINUING> (654,000) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (654,000) <EPS-PRIMARY> (.05) <EPS-DILUTED> (.05)